Skip to content

The new combined PET-MR system NextGen PET-MR with syngo MR XA80A: Evaluation of diagnostic image quality and usability (software and hardware) in the clinical setting

The new combined PET-MR system NextGen PET-MR with syngo MR XA80A: Evaluation of diagnostic image quality and usability (software and hardware) in the clinical setting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036007
Enrollment
60
Registered
2025-01-31
Start date
2025-03-11
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PET-MR Diagnostic

Interventions

Group 1: Single PET-MR examination with an examination time of max. 30-45 minutes

Sponsors

Siemens Healthineers AG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients of legal age for whom a PET-CT examination is indicated and will be performed - Patients of legal age who have given their written informed consent to participate in the clinical trial - Written consent of the patient to be informed in the event of suspected clinically relevant incidental findings - written consent to the disclosure of a clinically relevant incidental finding to a subsequent physician (release from the duty of confidentiality) - The patient's written consent that the recorded image data may be made available to Siemens Healthineers AG in pseudonymized form - Patients whose weight does not exceed the permissible weight limit of the patient table (200 kg).

Exclusion criteria

Exclusion criteria: - metal in and on the body that leads to exposure of the subject during an examination in the FoV of the combined PET-MR system - all pacemakers and other implants from different manufacturers that are not labeled as MR safe or MR conditional - Pregnancy: The exclusion of study participants of childbearing potential is carried out by questioning to ensure that only study participants who are in the first half of their menstrual cycle may be included. In case of doubt, the study will not be conducted. - Persons who indicate an increased sensitivity to loud noises - Persons who are not of legal age or incapable of giving consent

Design outcomes

Primary

MeasureTime frame
Evaluation of the diagnostic image quality (software and hardware) of the novel combined PET-MR system NextGen PET-MR in the clinical setting. Evaluation is carried out after the PET-MR examination by nuclear medicine physicians and radiologists using a 5-point Likert scale.

Secondary

MeasureTime frame
Evaluation of diagnostic image quality, image resolution and image post-processing Evaluation of the diagnosability of routine examinations in different body regions Comparison to current state-of-the-art hybrid examinations on PET-CT or PET-MR Investigation of clinical safety and possible occurrence of adverse events Evaluation of the additional requirements for the hybrid examination as defined in the scope of the investigation Patient Comfort Assessment Evaluation of system stability, performance, and safety in the clinical setting Evaluation is carried out after the PET-MR examination by nuclear medicine physicians and radiologists using a 5-point Likert scale.

Countries

Germany

Contacts

Public ContactMichael Beck

Universitätsklinikum Erlangen

nu-info@uk-erlangen.de09131 85-33411

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026